Literature DB >> 9197534

Mutational analysis of BRCA1 gene in ovarian and breast-ovarian cancer families in Japan.

M Takano1, H Aida, I Tsuneki, K Takakuwa, I Hasegawa, H Tanaka, M Saito, S Tsuji, T Sonoda, M Hatae, J T Chen, K Takahashi, K Hasegawa, N Toyoda, N Saito, M Yakushiji, T Araki, K Tanaka.   

Abstract

We analyzed the alteration of BRCA1 in DNA obtained from 83 individuals of 13 Japanese site-specific ovarian cancer families and 6 breast-ovarian cancer families. Six germline mutations were detected in 7 families, which consisted of 4 breast-ovarian cancer and 3 site-specific ovarian cancer families, by single-strand conformation polymorphism analysis, followed by direct sequence determination. The mutations included three frameshifts, two nonsense mutations, and one missense mutation causing loss of a zinc-binding motif. The frequency of loss of heterozygosity at the microsatellite markers on the BRCA1 gene was 57% (8 of 14 cases) in site-specific ovarian cancer families, and 100% (6 of 6 cases) in breast-ovarian cancer families. All tumors of the patients carrying a mutation of BRCA1 showed deletion of wild-type alleles, implicating BRCA1 as a tumor suppressor gene. These results suggest that germline mutations of the BRCA1 gene play an important role in the carcinogenesis of breast and/or ovarian cancer in a majority of breast-ovarian cancer families and in some site-specific ovarian cancer families.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9197534      PMCID: PMC5921420          DOI: 10.1111/j.1349-7006.1997.tb00397.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  26 in total

1.  A common BRCA1 mutation in the Ashkenazim.

Authors:  D E Goldgar; P R Reilly
Journal:  Nat Genet       Date:  1995-10       Impact factor: 38.330

2.  A somatic BRCA1 mutation in an ovarian tumour.

Authors:  L Hosking; J Trowsdale; H Nicolai; E Solomon; W Foulkes; G Stamp; E Signer; A Jeffreys
Journal:  Nat Genet       Date:  1995-04       Impact factor: 38.330

3.  Complete multipoint sib-pair analysis of qualitative and quantitative traits.

Authors:  L Kruglyak; E S Lander
Journal:  Am J Hum Genet       Date:  1995-08       Impact factor: 11.025

4.  Use of adoptive transfer of tumor-infiltrating lymphocytes alone or in combination with cisplatin-containing chemotherapy in patients with epithelial ovarian cancer.

Authors:  Y Aoki; K Takakuwa; S Kodama; K Tanaka; M Takahashi; A Tokunaga; T Takahashi
Journal:  Cancer Res       Date:  1991-04-01       Impact factor: 12.701

5.  Linkage of early-onset familial breast cancer to chromosome 17q21.

Authors:  J M Hall; M K Lee; B Newman; J E Morrow; L A Anderson; B Huey; M C King
Journal:  Science       Date:  1990-12-21       Impact factor: 47.728

6.  A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.

Authors:  Y Miki; J Swensen; D Shattuck-Eidens; P A Futreal; K Harshman; S Tavtigian; Q Liu; C Cochran; L M Bennett; W Ding
Journal:  Science       Date:  1994-10-07       Impact factor: 47.728

7.  The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals.

Authors:  J P Struewing; D Abeliovich; T Peretz; N Avishai; M M Kaback; F S Collins; L C Brody
Journal:  Nat Genet       Date:  1995-10       Impact factor: 38.330

8.  Mutation analysis of the BRCA1 gene in ovarian cancers.

Authors:  H Takahashi; K Behbakht; P E McGovern; H C Chiu; F J Couch; B L Weber; L S Friedman; M C King; M Furusato; V A LiVolsi
Journal:  Cancer Res       Date:  1995-07-15       Impact factor: 12.701

9.  Germline mutation of BRCA1 in Japanese breast cancer families.

Authors:  R Inoue; T Fukutomi; T Ushijima; Y Matsumoto; T Sugimura; M Nagao
Journal:  Cancer Res       Date:  1995-08-15       Impact factor: 12.701

10.  Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype-phenotype correlation.

Authors:  S A Gayther; W Warren; S Mazoyer; P A Russell; P A Harrington; M Chiano; S Seal; R Hamoudi; E J van Rensburg; A M Dunning; R Love; G Evans; D Easton; D Clayton; M R Stratton; B A Ponder
Journal:  Nat Genet       Date:  1995-12       Impact factor: 38.330

View more
  5 in total

Review 1.  The genetics of inherited breast cancer.

Authors:  S A Gayther; P D Pharoah; B A Ponder
Journal:  J Mammary Gland Biol Neoplasia       Date:  1998-10       Impact factor: 2.673

2.  Identification and evaluation of 55 genetic variations in the BRCA1 and the BRCA2 genes of patients from 50 Japanese breast cancer families.

Authors:  Masanori Kawahara; Masato Sakayori; Kazuko Shiraishi; Tadashi Nomizu; Motohiro Takeda; Rikiya Abe; Noriaki Ohuchi; Seiichi Takenoshita; Chikashi Ishioka
Journal:  J Hum Genet       Date:  2004-05-27       Impact factor: 3.172

3.  Screening of BRCA1 mutation using immunohistochemical staining with C-terminal and N-terminal antibodies in familial ovarian cancers.

Authors:  K Kashima; T Oite; Y Aoki; K Takakuwa; H Aida; H Nagata; M Sekine; H J Wu; Y Hirai; Y Wada; K Yamamoto; K Hasegawa; T Sonoda; T Maruo; I Nagata; M Ohno; M Suzuki; I Kobayashi; K Kuzuya; T Takahashi; Y Torii; K Tanaka
Journal:  Jpn J Cancer Res       Date:  2000-04

4.  Nonsense mutation at codon 63 of the BRCA1 gene in Japanese breast cancer patients.

Authors:  G Kijima; Y Murakami; N Ohuchi; S Satomi; T Sekiya
Journal:  Jpn J Cancer Res       Date:  1998-08

5.  Germline mutations in cancer-predisposition genes in patients with biliary tract cancer.

Authors:  Takeshi Terashima; Kumiko Umemoto; Hideaki Takahashi; Hiroko Hosoi; Erina Takai; Shunsuke Kondo; Yasunari Sakamoto; Shuichi Mitsunaga; Izumi Ohno; Yusuke Hashimoto; Mitsuhito Sasaki; Masafumi Ikeda; Kazuaki Shimada; Shuichi Kaneko; Shinichi Yachida; Kokichi Sugano; Takuji Okusaka; Chigusa Morizane
Journal:  Oncotarget       Date:  2019-10-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.